Dr. Landis actively participates in clinical trials with Dermatology Specialists Research. Dr. Landis first began working with DS Research in 2012 specializing in pediatric and adult acne. In addition to her acne specialty, she has taken part in numerous research trials as a sub-investigator for atopic/contact dermatitis, psoriasis, rosacea, and more. After 5 years of working and training under Dr. Joseph Fowler, Jr., M.D. as a sub-investigator, Dr. Landis now has the lead role as Principal Investigator for the DS Research facility in New Albany, Indiana. Through her work with DS Research, Dr. Landis works with some of the world’s largest pharmaceutical companies and contract research organizations to conduct Phase II-IV, observational and post-marketing clinical research studies.
Dr. Landis is dedicated to helping to find new, advanced treatments to not only improve the skin but to improve patient's overall quality of life. As a Clinical Associate Professor of Dermatology at the University of Louisville, Dr. Landis enjoys working with dermatology residents in the clinical setting as an Attending Physician at the Robley Rex Veterans Administration Medical Center. She also enjoys teaching the residents as a lecturer at the department’s Dermatology Conferences. Dr. Landis teaches to strengthen the specialty of dermatology and to keep her skills sharp. She thrives on lifelong learning and enjoys the educational environment and the enthusiasm of learners.
His main interests are in epidemiology and genetics, in particular in psoriasis and skin cancer including primary cutaneous lymphomas. He works and publishes general systems for epidemiologic methodology and classification of skin diseases. He is a member of several scientific societies and editorial boards, a member of the board of the German Dermato-Oncology Group (DeCOG), and co-chair of the Topic Advisory Group for the ICD-11 dermatology classification at the World Health Organization.
He is also the Director of Japanese Surgical Society and the President of Japanese Society of Regenerative Medicine. He earned a medical degree from Osaka University Medical School in 1980 and joined the First Department of Surgery, Osaka University School of Medicine. In 1989, he earned Humboldt scholarship to pursue further education in both the departments of cardiovascular physiology and cardiac surgery at the Max-Planck Institute in Germany. After returning to Japan, he became Chief surgeon at the Department of Cardiovascular Surgery in 2004, Professor and Chief at the Department of Cardiovascular Surgery, the Director at Medical Center for Translational Research at Osaka University Hospital in 2006. He was appointed to the Dean at Osaka University Graduate School of Medicine from 2015 – March 2017.
Recently, He has oriented his research toward establishing neural features associated with consciousness. he is leading a multimodal PET/fMRI study of brain mechanisms associated with the serotonin psychedelic psilocybin, to better understand how this promising and broadly applicable therapeutic affects the brain. He is collaborating with neurologists at Rigshospitalet including a project evaluating fMRI measures in coma patients to identify neural markers of conscious awareness and recovery.
This section has yet to be updated by the user.